Eric Alonzo

Senior Scientist
bluebird bio
Philipp Nold
Dr. Alonzo, currently leads the CAR T cell analytics team within the Process Development Department at bluebird bio. His research focuses on development of analytical and characterization assays for the CAR T/TCR cell program. Prior to bluebird bio, Dr. Alonzo lead efforts developing T cell-based therapies at Agenus (Lexington, MA), and previous to his work at Agenus, he was a postdoctoral fellow at Massachusetts General Hospital/Harvard Medical School working on a mouse model of T cell acute lymphoblastic leukemia. Dr. Alonzo received his PhD from the Cancer Biology Program at the Memorial Sloan-Kettering Cancer Center.


October 29 2019, 16:20
 - 16:50
Leveraging High-Dimensional-omics Technologes For Comprehensive Profi ling Of CAR T Cells To Resolve Drug Product Complexity

Other Speakers